Evofem Biosciences Inc (OTCPK:EVFM)
$ 0.01 0.00004 (0.4%) Market Cap: 1.00 Mil Enterprise Value: 50.34 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q2 2020 Evofem Biosciences Inc Earnings Call Transcript

Aug 04, 2020 / 03:00PM GMT
Release Date Price: $5662.47 (-5.63%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Evofem Biosciences Second Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded (Operator Instructions)

I would now like to hand the conference over to your speaker today, Ms. Amy Raskopf, Evofem Biosciences Head of Investor Relations. Ma'am, please go ahead.

Amy Raskopf
Evofem Biosciences, Inc. - Head of IR

Thank you, and good morning, everyone. Welcome to the Evofem Biosciences Q2 conference call. If you haven't done so already, I encourage you to access the Q2 2020 presentation and the press release we issued earlier today, both of which are at evofem.com under the Investors tab.

Before we begin, I would like to remind you that remarks on this call will contain forward-looking statements, which are made only as of today, August 4, 2020. For a more detailed description of important risk factors that could cause our actual results to differ materially, please refer to our annual report on Form 10

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot